Search

141 Result(s)
Sort by

Our Contribution

Our Contribution

Humanity is facing serious challenges. We believe we can always do more – for ourselves and for the generations to come. Click here to find out more.
Women in STEM 2022

Women in STEM 2022

Meet three of Boehringer Ingelheim's female scientists and learn why and how women are making a difference in STEM. Click here to find out more.
Conversations Beyond Type 2 Diabetes

Conversations Beyond Type 2 Diabetes

Anne and Franc, who are living with type 2 diabetes, explore what it means to live with their condition and its associated comorbidities. Find out more.
From Idea to Drug

From Idea to Drug

Development of a new drug starts with the hunt for effective compounds and finishes with the approval of the drug. Click here to learn more.
COVID-19 France Support to Pasteur Institute

COVID-19 France Support to Pasteur Institute

As part of our Global Donation Program, we are supporting research on COVID-19 in France. Click here to learn more information about the support.
Our Commitment

Our Commitment

We want to create value in areas of unmet medical need and engage with communities and society to improve lives – for humans and animals. Find out more.
COVID-19 Protecting Our Employees

COVID-19 Protecting Our Employees

We have taken precautions to protect our employees health and mitigate the risk of COVID-19 affecting our organisation. Click here to find out more.
1988-2015

1988-2015

Following the death of Hubertus Liebrecht (1991), the owning family made some fundamental decisions regarding the company’s alignment. Learn more here.
COVID-19 Learning from the pandemic

COVID-19 Learning from the pandemic

Online training options develop vets and other animal health professionals’ skills helping them overcome movement restrictions to thrive around the globe.
Innovation Through Cooperation

Innovation Through Cooperation

Exchange of information between pharmaceutical manufacturers and healthcare professionals is essential for patients. Click here to learn more.
COVID-19: Research Update

COVID-19: Research Update

Boehringer Ingelheim stops treatment with experimental medication in study investigating benefits for severely ill patients with COVID-19. Learn more.
Pet industry trends Millennials
Millennials are now shaping pet markets and facing new issues in pet healthcare. Click here to read and learn more about this new generation of pet owners.
One step further in fighting rabies in Vietnam

One step further in fighting rabies in Vietnam

A expedition team set off to the Duc Hue District. The purpose? To vaccinate the entire dog and cat population of several villages. Find out more.ral villages.
Lyon

Lyon

Boehringer Ingelheim has a research and production network across the globe. Click here to read and find out information about our Lyon site.
Innovation Needs Transparency

Innovation Needs Transparency

At Boehringer Ingelheim, we prioritise the establishment and maintenance of public trust. Transparency is therefore a key pillar of our corporate culture.
COVID-19 Mexico - The value of teamwork

COVID-19 Mexico - The value of teamwork

During the pandemic, Fabiola Villegas, contributed with creativity and ingenuity from her region in Uruapan, Michoacán, Mexico. Click here to learn more.
COVID-19 IMI2–Call 21

COVID-19 IMI2–Call 21

CARE launched to accelerate therapy development against COVID-19 and future coronavirus threats.